CLL Microlearning Series – Video #5: Managing Common Side Effects
Managing Common Side Effects
BTK inhibitors like zanubrutinib are effective and generally well-tolerated, but many patients experience early, non-dangerous side effects that can impact comfort and adherence.
In this video, an APP specializing in CLL reviews the most common symptoms patients report and shares practical strategies clinicians can use to support management and keep patients on therapy.
In This Video, You’ll Learn:
- The most common BTK-related side effects, including bruising, diarrhea, myalgias, arthralgias, and rashes
- Why these symptoms often appear early in therapy and how they typically improve over time
- Practical counseling tips: antidiarrheals, magnesium supplementation, stretching, and topical steroids
- The importance of early check-ins to assess new symptoms and reinforce adherence
- How to counsel patients on holding zanubrutinib around procedures to reduce bleeding risk